Overview

CJC-1295 DAC is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH). Used primarily in research settings, this peptide holds promise for enhancing plasma levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). The inclusion of a drug affinity complex (DAC) means that CJC-1295 DAC can have an extended half-life, allowing researchers to explore its effects over a more prolonged period. If you’re looking to add a powerful agent to your research on hormonal regulation, CJC-1295 DAC could be a valuable tool.

Key Features

Synthetic analog of growth hormone-releasing hormone.
Enhances plasma levels of growth hormone and IGF-1.
Prolongs half-life through drug affinity complex.
Ideal for advanced research applications.
Available in a convenient 5mg vial.

Specifications

Property	Details
Peptide Name	CJC-1295 DAC
Quantity	5mg
Category	Biotech Peptides

FAQ

What is CJC-1295 DAC used for?

CJC-1295 DAC is primarily used in research to study its effects on growth hormone and IGF-1 levels.

How is CJC-1295 administered?

This peptide is typically administered via injection, following research protocols.

Are there any side effects?

As with any synthetic peptide, it’s crucial to conduct thorough research and follow guidelines to understand potential effects.

For those interested in enhancing their research capabilities, consider exploring other peptide options such as N-Acetyl Selank or Vialox. These products, along with CJC-1295 DAC, can provide comprehensive insights into peptide functionality. Shop now and elevate the quality of your research with our premium offerings.